Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (ALK) as a marker

Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (ALK) as a marker

US Patent 10620207 · Granted Apr 14, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems and methods for meso-dissection2025
Materials and methods for performing histochemical assays for human pro-epiregul2025
Systems for automated in situ hybridization analysis2025
Computational pathology approach for retrospective analysis of tissue-based comp2025
Method for tissue sample fixation2024
Methods and systems for evaluation of immune cell infiltrate in tumor samples2024
Assessing risk of breast cancer recurrence2024
Informatics platform for integrated clinical care2024
Systems for automated in situ hybridization analysis2024
Computational pathology approach for retrospective analysis of tissue-based comp2024
Representative diagnostics2024
Systems and methods for meso-dissection2024